Actually transacted drug pricing system should be abolished, experts say

Korea should abolish the current incentive based pricing system as the differences between reported and actual prices still exists, market experts claim.

On top of that, they say the prevailing drug pricing reform has been blamed for a fiercer price dumping in hospital tender markets while illegal rebate practices are not eliminated.

Two years ago, the government came up with a plan to of...